abstract |
The present invention inhibits the expression of MDC and TARC in HaCaT cells, human keratinocytes treated with INF-γ and TNF-α, and atopic severity index (SCORAD index) in animal models in which atopic dermatitis is induced with DNCB (dintrochlorobenzene). It discloses a curryya arborea extract effective for atopic dermatitis, such as lowering the level and lowering the concentration of IgE in the blood. |